share_log

Shuttle Pharmaceuticals | 8-K: Shuttle Pharma Ready to Enroll patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharmaceuticals | 8-K: Shuttle Pharma Ready to Enroll patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Shuttle Pharmaceuticals | 8-K:Shuttle Pharma准备招募患者参加用于治疗胶质母细胞瘤患者的罗吡氧尿定2期临床试验
美股SEC公告 ·  08/14 16:21
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息